What should pediatrician know about selective IgA deficiency (update 2017)
Journal Title: Здоров`я дитини - Year 2017, Vol 12, Issue 7
Abstract
The article presents analysis of the current state of selective immunoglobulin A deficiency (SIgAD) from the point of view of the world’s leading experts, based on the results of epidemiological, genetic, molecular studies with high level of evidence. Selective IgA deficiency is the most common primary immunodeficiency and is characterized by an isolated deficiency of IgA, with usually normal levels of IgM and IgG in patients older than 4 years. Some IgG subclasses may be reduced in some patients with IgA deficiency. It is assumed that the overall incidence of selective IgA deficiency is 1 : 500–1 : 2000, but may be higher as most SIgADs have asymptomatic course, and there is no IgA deficiency screening program. IgA deficiency is facilitated by a complex network of genetic effects, namely IFIH1 loci on chromosome 2 and HLA-DQA1 on chromosome 6, with IgA-deficient-linked PVT1 (8 chromosomes), ATG13-AMBRA1 (11 chromosomes), AHI1 (6 chromosomes), and CLEC16A (16 chromosomes), including genes that are known to affect the physiology of IgA production. Most people with SIgAD are asymptomatic carriers, for some patients, pulmonary infections, allergies, autoimmune diseases, gastrointestinal diseases and malignant neoplasms are characteristic. Monitoring of patients with SIgAD consists of various methods, including education, the treatment of allergic or autoimmune diseases, the use of long courses or even the prophylactic use of antibiotics, the use of polyvalent pneumococcal vaccines and intravenous or subcutaneous substitution therapy with immunoglobulins. SIgAD prognosis mainly depends on the phenotype. There have been rare cases of spontaneous recovery, especially in young patients. Rarely, selective IgA deficiency may progress to the overall variable immunodeficiency. We consider it expedient to use the world experience in the diagnosis and treatment of selective IgA deficiency as the basis for patients’ monitoring in Ukraine.
Authors and Affiliations
O. L. Logvinova, M. O. Gonchar, O. P. Pomazunovska
Keywords
Related Articles
- EP ID EP249235
- DOI 10.22141/2224-0551.12.7.2017.116188
- Views 74
- Downloads 0
Screening of Blood Plasma Cholesterol Level in Children from Families of Patients with Diabetes Mellitus
The objective of the work — to carry out a screening study of total cholesterol level in the blood plasma of children from families of patients with diabetes mellitus of both types. Materials and methods of the study. Th...
Problems of Somatic Pathology in Children with Autistic Spectrum Disorders
Autistic spectrum disorders (ASD) — a complex deviation that is caused by developmental disorders of the brain and is characterized by severe comprehensive deficit of social interaction and communication, as well as rest...
The problem of effective and safe treatment of acute respiratory infections in children
As the etiological structure of acute respiratory viral infections (ARVI) is polymorphic, the presence of clinical manifestations very rarely allows to establish a connection with a particular pathogen and to prescribe t...
The Use of Crystalloid Solutions in Fluid Therapy in Children (Literature Review)
Intravenous infusion therapy recently has a significant upward trend. Recommendations of M.A. Holliday, W.E. Segar included in the basis of fluid therapy led to predominant use of hypotonic solutions. Hyponatremia, which...
PIVKA II as an Indicator of Vitamin K Deficiency in Children of the First Months of Life, Exclusively Breastfed Ukrainian Research
Background. Breastfed infants and babies in their first months of life especially, are naturally prone to a deficiency of vitamin K. The aim of our research was to clarify the frequency of determination, within the Ukrai...